The Prostate Cancer Foundation (PCF) and Bayer are pleased to announce a Request for Team Science Applications for BayerPCF Health Equity Research Awards for novel health equity implementation research projects with the goal of reducing racial and ethnic disparities in the diagnosis and treatment of advanced prostate cancer. These awards will be funded depending on the level of innovation in applications received. PCF and Bayer seek high-risk, currently unfunded projects from academic institutions in the United States (U.S. only). Bayer-PCF Health Equity Research Awards: • Composed of a team of at least three (3) investigators from qualified academic research centers in the U.S., including one young investigator (see Health Equity Research Award Team requirements below). • Support novel health equity implementation research projects with the goal of reducing prostate cancer racial and ethnic disparities, over a duration of two years. • Provide up to a total of $200,000 per team over two years. Approximately $500,000 USD will be designated for this award mechanism. • Cover only direct research costs and travel to the Annual PCF Scientific Retreat. • Clinical trial costs are not allowed; however, correlative research to support high impact clinical trials for advanced prostate cancer is encouraged. IRB submission and preferably approval is desired at time of application. • Comprehensive statistical plans and power calculations are required. • Community-health based research projects are encouraged, however the Principal Investigator of the study must have a primary appointment at a qualified academic institution.
Prostate Cancer Foundation, Bayer
Application Due Date